Company news: Lilly, Merck KGaA

Share this article:

Eli Lilly released a diabetes app Tuesday that is aimed at educating caregivers. The Lilly Glucagon Mobile App is designed for iPhones and iPads and teaches users how to inject Glucagon into type 1 diabetics as well as provides background information about how Glucagon helps patients manage diabetes. The injection is for severe hypoglycemia.

Merck KGaA's “Fit for 2018” plan calls for thinning employee ranks by 1,100 positions. The company said in a statement that the majority of the job cuts will come through attrition – voluntary resignations and early retirements – and expects that most of the jobs will be gone by the end of 2015. The company said the gradual reduction was part of an agreement between employee and company representatives, and stipulated that active pink-slipping that is part of the company's efficiency strategy will not begin until the end of 2017 at the earliest, not including possible site closures that may occur in the interim.

Share this article:
You must be a registered member of MMM to post a comment.
 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.